Adverse effects of modeling substances in Cali, Colombia
Abstract
Introduction: The desire to improve one’s physical appearance through simple and economical methods has resulted in the indiscriminate application of modeling substances. As a result, iatrogenic allogenosis has emerged as an increasingly prevalent disease in Latin America.
Objective: To describe the epidemiological characteristics and adverse effects arising from the use of modeling substances in a group of patients from Cali, Colombia.
Materials and methods: We conducted a retrospective review of the medical records of patients who consulted for complications arising from the use of modeling substances during a six-year period.
Results: A total of 1,322 patients were included of whom 95.5% were women. Patients’ ages ranged from 19 to 83 years, with an average of 39 years. The most infiltrated anatomical site showing adverse effects due to modeling substances was the buttocks. The asymmetry and increased volume of the infiltrated site were the most common signs while pain, mood disturbances, and depression or anxiety were the most commonly perceived symptoms. A total of 41.8% of patients ignored what substances they had received, and 28.5% received biopolymers; these procedures were mostly performed by non-qualified personnel.
Conclusions: The care of these patients requires multidisciplinary teams to establish treatment alternatives to improve their quality of life. In addition, the regulation of establishments, as well as the surveillance, inspection, and control of the imports and use of these substances should be warranted.
Downloads
References
Gordillo J, Alegre E, Torres I, Mendieta M, Sastré N. Abordaje multidisciplinario de la enfermedad humana por infiltración de sustancias modelantes. Cir Plást Iberolatinoam. 2013;39:269-77. https://doi.org/10.4321/S0376-78922013000300009
International Society of Aesthetic Plastic Surgery. International survey on aesthetic/cosmetic procedures performed in 2018. Fecha de consulta: 27 de abril de 2020. Disponible en: https://www.isaps.org/wp-content/uploads/2019/12/ISAPS-Global-Survey-Results-2018-new.pdf
Cabo F, Alcolea J, Bové I, Pedret C, Trelles M. Ecografía de los materiales de relleno inyectables y su interés en el seguimiento diagnóstico. Cir Plást Iberolatinoam. 2012;38:179-87. https://doi.org/10.4321/S0376-78922012000200012
Martínez A, Asz D, Gutiérrez D, Serena T, Lozano A, Sánchez L, et al. A case series and a review of the literature on foreign modelling agent reaction: An emerging problem. Int Wound J. 2017;14:546-54. https://doi.org/10.1111/iwj.12643
Domínguez A, Haddad J, Torres I, Jiménez G, Satré N, Espinosa S. Enfermedad por modelantes: problemática actual en México y presentación de casos. Cir Plást Iberolatinoam. 2013;39:399-405. https://doi.org/10.4321/S0376-78922013000400010
Ricaurte A, Castaño D, Castro J, De Paz D, Echeverry D. Alogenosis Iatrogénica vs. alogenosis secundaria en Cali. A propósito de 12 casos. Colomb Forense. 2016;3:61-72. https://doi.org/10.16925/cf.v3i2.1778
Priego B, Cárdenas R, Pérez C, Rincón L, Torres G, Haddad J. Enfermedad humana por modelantes. Análisis de sustancias con espectrometría de resonancia magnética. Cir Plast. 2010;20:120-3.
Hu H, Fang H, Chiu Y. Delayed-onset edematous foreign body granulomas 40 years after augmentation rhinoplasty by silicone implant combined with liquid silicone injection. Aesthetic. Plast Surg. 2017;41:637-40. http://doi.org/10.1007/s00266-017-0790-6
Coiffman F. Alogenosis iatrogénica. Una nueva enfermedad. Cir Plást Iberolatinoam. 2008;34:1-8.
Sanz H, Eróstegui C. Alogenosis iatrogénica, el gran peligro de los biopolímeros. Rev Cient Cienc Med. 2010;13:31-4.
López C. Aplicación de biopolímeros o sustancias modelantes como un problema de salud pública en la ciudad de Cali (tesis). Cali: Universidad del Valle; 2018.
Broder K, Cohen S. An overview of permanent and semipermanent fillers. Plast Reconstr Surg. 2006;118(Suppl.3):7-14s. https://doi.org/10.1097/01.prs.0000234900.26676.0b
Liu M, Beynet D, Gharavi N. Overview of deep dermal fillers. Facial Plast Surg. 2019;35:224-9. https://doi.org/10.1055/s-0039-1688843
Bailey S, Cohen J, Kenkel J. Etiology, prevention, and treatment of dermal filler complications. Aesthet Surg J. 2011;31:110-21. https://doi.org/10.1177/1090820X10391083
Signorini M, Liew S, Sundaram H, De Boulle K, Goodman G, Monheit G, et al. Global aesthetics consensus: Avoidance and management of complications from hyaluronic acid fillers - evidence- and opinion-based review and consensus recommendations. Plast Reconstr Surg. 2016;137:961-71. https://doi.org/10.1097/PRS.0000000000002184
Cohen J. Autoinflammatory/autoimmunity syndrome induced by adjuvants (ASIA; Shoenfeld’s syndrome): A new flame. Autoimmun Rev. 2018;17:1259-64. https://doi.org/doi:10.1016/j.autrev.2018.07.003
Jara L, Vera O, Medina G, Cruz M, Martínez M, García G, et al. Autoimmune/Inflammatory Syndrome Induced by Adjuvants (Shoenfeld’s Syndrome). In: Perricone C, Shoenfeld Y. Mosaic of autoimmunity: The novel factors of autoimmune diseases. London: Elsevier; 2019. p. 569-80.
Di Benedetto G, Pierangeli M, Scalise A, Bertani A. Paraffin oil injection in the body: An obsolete and destructive procedure. Ann Plast Surg. 2002;49:391-6. https://doi.org/10.1097/00000637-200210000-00010
Priego R, Rincón R, Serrano A, Torres B, Haddad J, Del Vecchyo C. Clasificación y tratamiento de la enfermedad mamaria por modelantes. Cir Plast. 2010;20:112-9.
Cala L, Navarro A, León J, Buitrago D, Teherán A. Características de individuos sometidos a infiltración de materiales extraños con fines estéticos sobre los que se realizó investigación judicial en Colombia. Cir Plast Iberolatinoam. 2017;43:137-41.
Some similar items:
- María Fernanda Corrales, Rodrigo Restrepo, Estefanía Calle, Daniela Morales, Biopolymer sarcoid-like foreign-body granulomas: Case report and literature review , Biomedica: Vol. 42 No. Sp. 1 (2022): Mayo, Enfermedades crónicas en el trópico

Article metrics | |
---|---|
Abstract views | |
Galley vies | |
PDF Views | |
HTML views | |
Other views |
Funding data
-
Departamento Administrativo de Ciencia, Tecnología e Innovación (COLCIENCIAS)
Grant numbers 210477758178